Brian Chiu to United States Food and Drug Administration
This is a "connection" page, showing publications Brian Chiu has written about United States Food and Drug Administration.
Connection Strength
0.021
-
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Ann Oncol. 2011 May; 22(5):1170-1180.
Score: 0.021